Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05332015
Other study ID # 4/2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 28, 2022
Est. completion date August 28, 2022

Study information

Verified date January 2023
Source Antalya Training and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

OBJECTIVE: The primary objective of our study is to compare the effects of routine hydration with additional 2 liters of normal water versus orally 2 liters of distilled water on the amount of amniotic fluid. HYPOTHESIS: İsolated oligohydramnios, secondary to depleted maternal intravascular volume, can be reversed better with orally hypotonic water.


Description:

BACKGROUND: Olygohydramniosis is a condition in which amniotic fluid levels are lower than expected for gestational age. It is typically diagnosed by ultrasound examination and may be described qualitatively (e.g., reduced amniotic fluid volume) or quantitatively (e.g., amniotic fluid index ≤5 cm, single deepest pocket <2 cm). Water hydration aims to decrease maternal osmolality and sodium concentration, increase water flow osmotically from maternal blood to fetal amniotic fluid, and improve uteroplacental perfusion. A meta-analysis comparing maternal hydration's effect reported that maternal intravenous hydration had good results on AFI in pregnancies with isolated oligohydramnios and hypotonic solutions were more effective than isotonic fluids(1). Maternal oral hydration may slightly increase amniotic fluid and is safer than intravenous fluid administration or amnioinfusion. Reducing the osmolality in maternal blood with oral hypotonic and isotonic fluids helps to direct the placental water passage towards the fetus, to improve uteroplacental perfusion, and as a result, to increase the amount of amniotic fluid in pregnant women with isolated oligohydramnios. Osmolality is further reduced by maternal oral hypotonic fluid, thus improving the amount of amniotic fluid. The study protocol was approved by the Local Ethics Committee, and written informed consent will be taken from patients entering the study. The sample size was calculated based on the "Maternal hydration increases amniotic fluid index" study of Kilpatrick et al.(2). When 1.5 cm increase in AFI is considered significant, with 90% power and type 2 error (alpha): 0.05, the sample size is 20 for each group, and it is planned to include 40 pregnant women in total. I


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date August 28, 2022
Est. primary completion date June 28, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Singleton pregnancy - Gestational age (GA) 28-39 weeks (based on the last menstrual period and confirmed by the results of ultrasound or determined through early pregnancy sonography) - Isolated oligohydramnios cases - Amniotic fluid index = 5 - No pregnancy complications such as preeclampsia, gestational hypertension - Intact fetal membranes. Exclusion Criteria: - Presence of fetal complications (membrane rupture, presence of fetal anomaly, intrauterine growth restriction) - Presence of maternal systemic disease (nephropathy, cardiac disease) - Multiple pregnancies - Conditions in which the amount of amniotic fluid cannot be accurately assessed (morbid obesity)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Hypotonic (distilled) water
orally given daily two liters of distilled water
Normal water
orally given daily two liters of normal water

Locations

Country Name City State
Turkey Antalya Training and Research Hospital Antalya Muratpasa

Sponsors (1)

Lead Sponsor Collaborator
Antalya Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Gizzo S, Noventa M, Vitagliano A, Dall'Asta A, D'Antona D, Aldrich CJ, Quaranta M, Frusca T, Patrelli TS. An Update on Maternal Hydration Strategies for Amniotic Fluid Improvement in Isolated Oligohydramnios and Normohydramnios: Evidence from a Systematic Review of Literature and Meta-Analysis. PLoS One. 2015 Dec 11;10(12):e0144334. doi: 10.1371/journal.pone.0144334. eCollection 2015. — View Citation

Kilpatrick SJ, Safford KL, Pomeroy T, Hoedt L, Scheerer L, Laros RK. Maternal hydration increases amniotic fluid index. Obstet Gynecol. 1991 Dec;78(6):1098-102. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants With Reversal of Oligohydramnios Using AFV Measures The change between the basal amniotic fluid index and the value on day 7 admission, day 7
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03277417 - Does Amniotic Fluid Index Affect the Fetal Cardiac Performance? N/A
Recruiting NCT00787163 - Amnioinfusion Initiative Phase 3
Completed NCT05059093 - Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
Not yet recruiting NCT05043753 - "Fetal gRowth AbnorMality dEtection Trial" N/A
Recruiting NCT02997345 - PPROM Registry (Preterm Premature Rupture of Membranes)
Completed NCT03935607 - The Added Contribution of Transvaginal Sonographic Evaluation of Amniotic Fluid Index
Completed NCT02581774 - Active Induction of Labor in Pregnancies Complicated With Oligohydramnios at Term Phase 4
Terminated NCT01569035 - Warfarine in Unexplained Oligohydramnios Phase 4
Completed NCT01140971 - Foley Catheter Versus Vaginal Misoprostol for Cervical Ripening and Induction of Labor N/A
Recruiting NCT04684680 - The Role of Zamzam Water in Idiopathic Oligohydramnios N/A
Not yet recruiting NCT03815968 - Low Sodium Diet in Oligohydramnios Assigned for Conservative Management N/A
Enrolling by invitation NCT04451109 - Dilapan-S®: A Multicenter US E-registry
Recruiting NCT02901340 - Fetal Renal Artery Doppler Indices in Borderline Isolated Oligohydramnios N/A
Terminated NCT01682928 - Hydrotherapy for the Reversal of Oligohydramnios N/A
Not yet recruiting NCT05474326 - Effect of Intermittent Pneumatic Compression Device of Lower Limbs in Oligohydramnios N/A